Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
VMF
0
Canada
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. E5501 Maleate
2. 677007-74-8
3. Avatrombopag Maleate [usan]
4. Avatrombopag Meleate
5. Avatrombopag (maleate)
6. Gdw7m2p1is
7. E-5501 Maleate
8. (z)-but-2-enedioic Acid;1-[3-chloro-5-[[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]carbamoyl]pyridin-2-yl]piperidine-4-carboxylic Acid
9. 4-piperidinecarboxylic Acid, 1-(3-chloro-5-(((4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1- Piperazinyl)-2-thiazolyl)amino)carbonyl)-2-pyridinyl)-, (2z)-2-butenedioate (1:1)
10. Unii-gdw7m2p1is
11. Doptelet (tn)
12. Akr-501 Monomaleate
13. Chembl2105758
14. Schembl19610454
15. Avatrombopag Maleate [mi]
16. Avatrombopag Maleate (jan/usan)
17. Avatrombopag Maleate [jan]
18. Dtxsid001027855
19. 677007-74-8 (maleate)
20. Hy-13463a
21. Avatrombopag Maleate [who-dd]
22. Avatrombopag Maleate [orange Book]
23. Cs-0025423
24. D10307
25. A902459
26. Q27279052
27. 1-(3-chloro-5-((4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2- Yl)carbamoyl)pyridin-2-yl)piperidine-4-carboxylic Acid Mono-(2z)-but-2-enedioate
28. 1-[3-chloro-5-[[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]carbamoyl]pyridin-2-yl]piperidine-4-carboxylic Acid;avatrombopag
Molecular Weight | 765.7 g/mol |
---|---|
Molecular Formula | C33H38Cl2N6O7S2 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 9 |
Exact Mass | 764.1620453 g/mol |
Monoisotopic Mass | 764.1620453 g/mol |
Topological Polar Surface Area | 233 Ų |
Heavy Atom Count | 50 |
Formal Charge | 0 |
Complexity | 1050 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Doptelet is indicated for the treatment of severe thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo an invasive procedure.
Doptelet is indicated for the treatment of primary chronic immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments (e. g. corticosteroids, immunoglobulins).
Treatment of Idiopathic Thrombocytopenia Purpura (ITP), Treatment of Thrombocytopenic Purpura Secondary to Liver Disease
B02BX
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Avatrombopag Maleate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Avatrombopag Maleate, including repackagers and relabelers. The FDA regulates Avatrombopag Maleate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Avatrombopag Maleate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Avatrombopag Maleate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Avatrombopag Maleate supplier is an individual or a company that provides Avatrombopag Maleate active pharmaceutical ingredient (API) or Avatrombopag Maleate finished formulations upon request. The Avatrombopag Maleate suppliers may include Avatrombopag Maleate API manufacturers, exporters, distributors and traders.
click here to find a list of Avatrombopag Maleate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Avatrombopag Maleate DMF (Drug Master File) is a document detailing the whole manufacturing process of Avatrombopag Maleate active pharmaceutical ingredient (API) in detail. Different forms of Avatrombopag Maleate DMFs exist exist since differing nations have different regulations, such as Avatrombopag Maleate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Avatrombopag Maleate DMF submitted to regulatory agencies in the US is known as a USDMF. Avatrombopag Maleate USDMF includes data on Avatrombopag Maleate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Avatrombopag Maleate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Avatrombopag Maleate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Avatrombopag Maleate Drug Master File in Korea (Avatrombopag Maleate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Avatrombopag Maleate. The MFDS reviews the Avatrombopag Maleate KDMF as part of the drug registration process and uses the information provided in the Avatrombopag Maleate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Avatrombopag Maleate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Avatrombopag Maleate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Avatrombopag Maleate suppliers with KDMF on PharmaCompass.